Let's take a look at three buy-rated ASX shares that Australians ought to consider as buy and hold investments for the next decade. They are as follows: The first ASX share that could be a good buy ...

Shares of ResMed Inc. RMD slipped 0.54% to $238.12 Tuesday, on what proved to be an all-around mixed trading session for the ...

ResMed shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82. Meet the ...

Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy.Canada - November 8, 2024 — Air ...

ResMed Inc (NYSE:RMD) reports a robust 11% increase in net revenue year-over-year. Significant growth in Sleep and Breathing Health segment, showcasing an 11% rise in sales. Strong gross margin ...

Hello, and welcome to the Q1 Fiscal Year 2025 ResMed Earnings Conference Call ... Our earnings press release and presentation are both available online now. During today's call, we will discuss ...

Revenue: US$1.22b (up 11% from 1Q 2024). Net income: US$311.4m (up 42% from 1Q 2024). Profit margin: 25% (up from 20% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: US$2.12 ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...

Oct 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal first-quarter profit of $311.4 million. The San Diego-based company said it had net income of $2.11 per share.

Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at https://investor.resmed.com SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD ...

For the three months ended 30 September, ResMed reported an 11% increase in revenue to US$1,224.5 million. This was largely in line with consensus estimates for the period. Management advised that ...